Detailed Analysis of Dr. Reddy's Laboratories Stock

Dr. Reddy's Laboratories Limited is an integrated pharmaceutical company operating globally, with a focus on drug manufacturing and specialty generics. The company has a strong presence in the healthcare sector and offers a wide range of pharmaceutical products and services.

Key Financial Statistics

• Current Price: INR 5868.8
• Market Cap: INR 978.97 billion
• Dividend Rate: INR 40.0
• PE Ratio: 17.55
• Volume: 237,285

Company Officers

The company is led by a team of experienced and qualified individuals who hold key positions, including Chairman, CEO, CFO, and other members of the Management Council.

Key Ratios and Margins

• Profit Margins: 19.95%
• Return on Assets: 11.67%
• Debt to Equity: 7.14
• Gross Margins: 58.61%

Analyst Recommendations

• Target High Price: INR 7500.0
• Target Low Price: INR 4245.0
• Recommendation: Hold
• Number of Analyst Opinions: 36

Conclusion

Dr. Reddy's Laboratories stock has shown strong financial performance with healthy profit margins and a positive outlook from analysts. The company's leadership team and focus on innovation position it well for future growth and success in the pharmaceutical industry.